about
Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cellsCharacterization of human vaginal mucosa cells for autologous in vitro cultured vaginal tissue transplantation in patients with MRKH syndrome.Potential prognostic and diagnostic application of a novel monoclonal antibody against keratinocyte growth factor receptor.Topical KGF treatment as a therapeutic strategy for vaginal atrophy in a model of ovariectomized mice.HE4 in the differential diagnosis of ovarian masses.TNFα modulates Fibroblast Growth Factor Receptor 2 gene expression through the pRB/E2F1 pathway: identification of a non-canonical E2F binding motif.Standard of care and promising new agents for triple negative metastatic breast cancerFibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic applicationGene expression profile of patients with Mayer-Rokitansky-Küster-Hauser syndrome: new insights into the potential role of developmental pathways.CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.Potential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages.KSHV ORF67 encoded lytic protein localizes on the nuclear membrane and alters emerin distribution.Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.In vivo and in vitro evidence for an association between the route-specific transmission of HHV-8 and the virus genotype.Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells.The BFRF1 gene of Epstein-Barr virus encodes a novel protein.Regulation of the expression of the Epstein-Barr virus early gene BFRF1.Phenotypic and genotypic characteristics of new euploid-diploid lymphoblastoid B cell lines EBV+, normal human bone marrow derived, spontaneously overgrown in vitro.Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina.BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress.Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakia lesions.Transcription of latent and replicative Epstein-Barr-virus genes in bone-marrow and peripheral-blood mononuclear cells of healthy donors.Neuramide inhibits Epstein-Barr virus-induced transformation activity and proliferation of transformed B lymphocytes.The role of calcium precipitation in the sulfoglycolithocholate-induced cholestasis of the bile fistula hamster.Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso.Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis.Susceptibility to human herpesvirus-8 infection in a healthy population from Sardinia is not directly correlated with the expression of HLA-DR alleles.High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy.The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold.Urine sepiapterin excretion as a new diagnostic marker for sepiapterin reductase deficiency.Comparison of the first fully automated agarose gel electrophoresis system with the Capillarys electrophoresis method for the identification of monoclonal immunoglobulinsLow 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancerHair Regeneration from Transected Follicles in Duplicative SurgeryOverexpression of the fibroblast growth factor receptor 2-IIIc in Kaposi's sarcomaModulation of the expression of the FGFR2-IIIb and FGFR2-IIIc molecules in dermatofibromaThe Benign Cystic Lymphoepithelial Lesion of the Parotid Gland Is a Viral Reservoir in HIV Type 1-Infected Patients
P50
Q21092205-057203E5-21BC-4827-9679-AC5D5134D31AQ34069635-34B5710E-C26F-481A-9652-E3201B3D22ACQ34136499-0B324F37-426D-49EC-8E6C-A4B516C80647Q34336891-55A67C9C-4B69-4CB1-A37E-28410E2510FFQ34669413-19BCF7DB-E8A6-4190-9A4D-AD671B1E7BCFQ34684477-0F993159-9FA0-4310-A571-2807CD705D9FQ34774884-1E23BC78-AFE6-4695-BFF2-E8D5114C8665Q34973710-40011A05-8471-446B-9D17-EB54DAF7954EQ35114881-9D82BC09-CD62-47EF-8093-819DD2081EC7Q36088171-41BA54BA-7B8D-4F79-9A57-2A6E6E17A48DQ37996468-7E9DBC39-5A4A-4FF2-9830-F2650B500EA9Q39159499-B13DDCD8-ED66-4576-8C5C-C15BEDB00671Q39205985-F2B22A55-C862-47A9-87CA-1CF3E7DB72BEQ39226249-613CCB8B-4505-4104-A073-13036847033AQ39268867-5D9C5750-0CFC-4919-82F0-0DC910D3A583Q39590218-35834709-E61D-4366-AD54-D69E18E4DB2DQ40331535-BD3CBA2D-63E0-4F93-985C-7C2723F156A1Q40431552-01202AB5-6522-4CB0-8B3F-65E2D4E7EFB0Q40454370-A2A9784B-5EC1-4AEA-812D-B3D82BF01A86Q40454379-49339F8C-F0B7-4334-AC03-4CD9D28F6344Q40613857-3FD3194B-EB51-440C-9E8C-7B451D7BA4B6Q41121317-F2FE9F2E-1501-4967-8662-A76777E67FD3Q41130814-7EA26B58-F8C5-477D-87B8-5550A006C71BQ41234467-73A6AAFE-2F6C-484D-8463-BE9BFC6283EAQ42986663-98540822-67BD-4B4C-B560-18317F7A70D5Q43588809-86485F65-89B1-4623-B684-81EEA802038EQ43838560-1816E0F0-04FB-459E-86BD-167E6FE55EA7Q47795261-28447474-425C-4809-9376-BE510380A722Q47971775-73F69AC0-9203-4607-8DF1-0F6028A6977BQ48102940-A30FFEA4-4C60-4B46-9241-387425ECBD24Q56836911-1CD02081-71E1-4F85-A78E-1E545225F919Q56836913-E629AAAF-1CE0-4BE1-94D8-D62985BDCBDCQ56836916-2FF3F816-C8D3-4C79-B6A2-C5F036CDDF9FQ56836919-0B078504-C8E7-421B-907E-CDC49E07C0D6Q56836921-E30FF173-48CE-485E-891A-795A69207B70Q56836925-C626F13D-32AC-499F-9C2C-B143D32B5FD8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antonio Angeloni
@ast
Antonio Angeloni
@en
Antonio Angeloni
@es
Antonio Angeloni
@fr
Antonio Angeloni
@nl
Antonio Angeloni
@sl
type
label
Antonio Angeloni
@ast
Antonio Angeloni
@en
Antonio Angeloni
@es
Antonio Angeloni
@fr
Antonio Angeloni
@nl
Antonio Angeloni
@sl
prefLabel
Antonio Angeloni
@ast
Antonio Angeloni
@en
Antonio Angeloni
@es
Antonio Angeloni
@fr
Antonio Angeloni
@nl
Antonio Angeloni
@sl
P1053
J-9392-2018
P106
P1153
7004160599
P21
P31
P3829
P496
0000-0003-4969-9548